(Guest Lecture) November 2022 - Integrative Medicine: Ideas for Myeloma Treatment

(Guest Lecture): November 2022 - How Myeloma Frontline Therapy is Changing - Ajai Chari, MD

(Guest Lecture): November 2022 - CAR-T: Ready for Prime Time?

(Guest Lecture) November 2022 - Physiatry: A New Approach Incorporating Proven Ideas

CAR-T: Ready for Prime Time? - Jesus Berdeja, MD | RT Irvine, CA Nov 5, 2022

Moderated Discussion and Round Table Audience Q&A One | RT Irvine, CA Nov 5, 2022

Round Table Audience Q&A Two | RT Irvine, CA Nov 5, 2022

Physiatry: A New Approach Incorporating Proven Ideas - Jessica Cheng, MD | RT Irvine, CA Nov 5, 2022

HealthTree Coach Program Discussion | RT Irvine, CA Nov 5, 2022

Amrita Krishnan Leads Faculty Discussion | RT Irvine, CA Nov 5, 2022

Pushing Toward Tomorrow - Amrita Krishnan, MD, FACP | RT Irvine, CA Nov 5, 2022

Integrative Medicine: Ideas for Myeloma Treatment - Richard Lee, MD | RT Irvine, CA Nov 5, 2022

Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022

How Myeloma Frontline Therapy is Changing - Ajai Chari, MD | RT Irvine, CA Nov 5, 2022

Can natural killer cells become exhausted?

What are natural killer cells? What is their job? How do they differ from t-cells?

How are NK cells being used in anti-myeloma therapy?

What is autologous NK cell therapy?

What is allogeneic NK therapy?

Are NK cells being used alone or in combination with other drugs?

What side effects are being seen with NK cell therapy?

What is the best setting to use NK cell therapy?